MyoWorx® Myofascial Treatment
The MyoWorx® approach reveals underlying injury that should be addressed prior to additional therapy. The key is to treat the source of the condition – not just the symptoms. It is a comprehensive approach that includes all phases of treatment – from a thorough initial assessment to in-clinic treatment and at-home care.
The TM20 Device
The TM20 device used in MyoWorx® treatment is the key to unlocking the potential for results. Clinical research indicates the use of the TM20 device will get you better sooner. Unlike any other electrotherapy machine, the TM20 device facilitates patient outcomes by doing the following:
- Provides pain-free treatment that mimics what the body does naturally to relax muscles
- Restores normal levels of blood flow, oxygen and nutrients in the muscles
- Reduces inflammation within the muscles
- Accelerates the effect of specific, targeted exercises
- Enhances the body’s response to hands-on treatment
Digging Deeper – MyoWorx® TM20 Patented Technology
Biochemical Changes for the Restoration of Long-Term Control of Blood Flow
When a muscle is contracted from fatigue or injury, the resultant effect is an overall reduction in blood flow. The reduced blood flow triggers an increased production of eicosanoids in the blood, specifically Leukotriene B4 (LTB4). The LTB4 causes the vessels of the muscle to become ‘leaky’, which increases the interstitial pressure on the vessels via the resultant edema surrounding them. This further triggers the enhancement of the biochemical cycle that releases LTB4. Therefore, there is a self-perpetuating cycle established, which will limit blood flow in the muscle and expose the muscle to reduced oxygen and nutrition and a greater rate of fatigue. Unchecked, this leads to chronic muscle tightness and shortening.
TM20 is a patented device that delivers a specified sequence of electrical frequencies in a timed manner. Pre-clinical studies showed these frequencies can:
Manipulation of the Muscle’s Cell Membranes to Normalize the Resting Membrane Potentials – Fatigued or injured muscle fibres maintain increased tone or contraction. Their resting membrane potential is hypo-polarized (more positive) and closer to threshold for an action potential to elicit contraction. The repeated pulses used in the MyoWorx® TM20 treatment manipulate the cell membrane potential de-polarizing but at levels just below threshold for contraction. This repeated manipulation of the cell membrane potential produces refractory hyper-polarizations returning the resting potential to a more negative level.
Creation of a Communication Loop with the CNS to use CNS Activity to Muscles to Help Relax the Fatigued or Injured Muscles – Using a specific abrupt frequency change from very low to higher, the CNS is triggered via the muscle spindle fibres to send relaxation signals to the muscle. This is because the CNS will perceive the muscle spindle fibres’ feedback as a change of tension. However, the CNS is aware that it has not signaled this supposed activity in the muscle and therefore it sends pulses to the muscle to relax it and restore homeostasis.
Muscle Flow, Muscle Fibre Relaxation and Increased Blood Flow – The physiological effect of specific frequencies on muscle tissue are derived from Terry Moore’s graduate research work, which studied the effects of varied stimulation patterns on muscle tension, blood flow and oxygen uptake. The frequencies used in the MyoWorx® TM20 treatment decrease the tension of the muscle fibres and lead to greater blood flow over the longer term.
MyoWorx® TM20 frequencies induce biochemical changes affecting the concentration of LTB4 in fatigued or injured muscle cells that diverts it to its derivatives: C4 and D4, which will drive the return to vaso-dilation and increased blood flow. Therefore, by altering the biochemical changes that also occur in fatigued or injured muscles, the treatment restores proper long-term control of blood flow and the delivery of oxygen and nutrition to the muscle.